![](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/10/9B7A4532-Pano-Edit-600x260.jpg)
October 13, 2020
UNC Neurology Plays Role in Successful Phase 2 Clinical Trial for Neflamapimod in Mild-to-Moderate Lewy Body Dementia
UNC Neurology’s Research Center of Excellence for Lewy Body Dementia participated as a study site for a phase 2 clinical trial that recently met its primary objective of improving cognition in LBD patients who received neflamapimod.